Brief: RhoVac Reports Positive And Constructive Response From EMA

Chosa Oncology AB

19/06/2018 12:54

June 19 (Reuters) - RHOVAC AB  RHOVAC.TE :
    * RHOVAC'S REPORTS POSITIVE AND CONSTRUCTIVE RESPONSE FROM
THE
EUROPEAN MEDICINES AGENCY IN THE NOW COMPLETED SCIENTIFIC ADVICE
PROCEDURE
    * RHOVAC AB  - EMA HAS STATED THAT THERE IS A CLEAR WINDOW
FOR
EARLY PROSTATE CANCER TREATMENT WITH RHOVAC'S DRUG CANDIDATE
RV001

Source text for Eikon:  ID:nWkr6g8T1V 
Further company coverage:  RHOVAC.TE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 587720920;))